Park Yong Chon, Lee Min-Soo, Si Tian-Mei, Chiu Helen F K, Kanba Shigenobu, Chong Mian-Yoon, Tripathi Adarsh, Udomratn Pichet, Chee Kok Yoon, Tanra Andi J, Rabbani Golam, Javed Afzal, Kathiarachchi Samudra, Myint Win Aung, Cuong Tran Van, Sim Kang, Yang Shu-Yu, Sartorius Norman, Tan Chay-Hoon, Shinfuku Naotaka, Park Seon-Cheol
Department of Neuropsychiatry, Hanyang University Guri Hospital, Guri, Republic of Korea.
Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea.
Saudi Pharm J. 2019 Feb;27(2):246-253. doi: 10.1016/j.jsps.2018.11.006. Epub 2018 Nov 13.
Although disorganized speech is seen as one of the nuclear features of schizophrenia, there have been few reports of disorganized speech-associated psychotropic drug-prescribing patterns in large samples of schizophrenia patients.
We aimed to examine the prevalence of disorganized speech and its correlates in terms of psychotropic drug prescribing, using the data from the Research on Asian Psychotropic Patterns for Antipsychotics (REAP-AP) study.
A total of 3744 patients with the ICD-10 diagnosis of schizophrenia were enrolled from 71 survey centers in 15 Asian countries/areas. An essential criterion of disorganized speech was that it was "severe enough to impair substantially effective communication" as defined in the DSM-5. A binary logistic model was fitted to identify the psychotropic drug-prescribing correlates of disorganized speech.
After adjusting for the potential effects of confounding variables, the binary logistic regression model showed that the presence of disorganized speech was directly associated with adjunctive use of mood stabilizers ( < 0.001) and cumulative diazepam equivalent dose ( < 0.0001), and inversely associated with adjunctive use of anti-Parkinson drugs ( < 0.0001).
The association between disorganized speech and adjunctive use of mood stabilizers could perhaps be understood in the context of a relationship with impulsiveness/aggressiveness, or in terms of deconstructing the Kraepelinian dualism.
尽管言语紊乱被视为精神分裂症的核心特征之一,但在大量精神分裂症患者样本中,关于言语紊乱相关精神药物处方模式的报道却很少。
我们旨在利用亚洲抗精神病药物模式研究(REAP-AP)的数据,研究言语紊乱的患病率及其在精神药物处方方面的相关因素。
从15个亚洲国家/地区的71个调查中心招募了总共3744例符合ICD-10精神分裂症诊断标准的患者。言语紊乱的一个基本标准是,按照《精神疾病诊断与统计手册》第5版的定义,它“严重到足以严重损害有效沟通”。采用二元逻辑模型来确定言语紊乱与精神药物处方的相关因素。
在调整混杂变量的潜在影响后,二元逻辑回归模型显示,言语紊乱的存在与辅助使用心境稳定剂(<0.001)和地西泮等效累积剂量(<0.0001)直接相关,与辅助使用抗帕金森药物(<0.0001)呈负相关。
言语紊乱与辅助使用心境稳定剂之间的关联或许可以在与冲动/攻击性的关系背景下理解,或者从解构克雷佩林二元论的角度来理解。